Since 2022, the American Diabetes Association has updated its Standards of Care to recommend GLP1 receptor agonists as a firstline therapy for T2D 2 , eroding older and cheaper generics like metformin, which marks a momentous and fundamental change in treatment
The GLP-1 headache complete guide covers causes and solutions, while whether tirzepatide causes headaches addresses tirzepatide-specific concerns
A 50:50 soluble-insoluble fiber blend supports digestive health and regularity while improving long-term metabolic function
Between early 2022 and mid-2024, more than 6 million patients were identified with a type 2 diabetes diagnosis
The hormone's combined central and peripheral effects are attributable to its capacity to traverse the bloodbrain barrier, facilitating extensive metabolic control (Prete et al
Patients should be educated on gastrointestinal side effects at treatment initiation